Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Tabuchi

Showing results (21-30 of 76) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|October 13, 2006
Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in JapanRyoji Kobayashi, Tadashi Ariga, Shigeaki Nonoyama, et al.
British Journal of Haematology|October 14, 2006
Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblingsRyoji Kobayashi, Hiromasa Yabe, Junichi Hara, et al.
Pediatric Blood & Cancer|October 15, 2009
Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in JapanShouichi Ohga, Kazuko Kudo, Eiichi Ishii, et al.
International Journal of Hematology|May 19, 2025
Hematopoietic cell transplantation in pediatric EB virus-associated hemophagocytic lymphohistiocytosisKenichi Sakamoto, Satoshi Miyamoto, Kohsuke Imai, et al.
International Journal of Hematology|March 13, 2012
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Tomohiko Taki, et al.
British Journal of Haematology|August 26, 2010
Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative studyMasue Imaizumi, Akio Tawa, Ryoji Hanada, et al.
Pediatric Blood & Cancer|December 17, 2015
Role of Second Transplantation for Children With Acute Myeloid Leukemia Following Posttransplantation RelapseTakashi Taga, Yoshitaka Murakami, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study GroupKazuko Kudo, Seiji Kojima, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study GroupIchiro Tsukimoto, Akio Tawa, Keizo Horibe, et al.
Pediatric Transplantation|January 26, 2016
Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell TransplantationShunichi Kato, Hiromasa Yabe, Hiromitsu Takakura, et al.
Pageof 8

Showing results (21-30 of 76) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|October 13, 2006
Outcome in patients with Wiskott-Aldrich syndrome following stem cell transplantation: an analysis of 57 patients in JapanRyoji Kobayashi, Tadashi Ariga, Shigeaki Nonoyama, et al.
British Journal of Haematology|October 14, 2006
Preceding immunosuppressive therapy with antithymocyte globulin and ciclosporin increases the incidence of graft rejection in children with aplastic anaemia who underwent allogeneic bone marrow transplantation from HLA-identical siblingsRyoji Kobayashi, Hiromasa Yabe, Junichi Hara, et al.
Pediatric Blood & Cancer|October 15, 2009
Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in JapanShouichi Ohga, Kazuko Kudo, Eiichi Ishii, et al.
International Journal of Hematology|May 19, 2025
Hematopoietic cell transplantation in pediatric EB virus-associated hemophagocytic lymphohistiocytosisKenichi Sakamoto, Satoshi Miyamoto, Kohsuke Imai, et al.
International Journal of Hematology|March 13, 2012
RAS mutations are frequent in FAB type M4 and M5 of acute myeloid leukemia, and related to late relapse: a study of the Japanese Childhood AML Cooperative Study GroupHirozumi Sano, Akira Shimada, Tomohiko Taki, et al.
British Journal of Haematology|August 26, 2010
Prospective study of a therapeutic regimen with all-trans retinoic acid and anthracyclines in combination of cytarabine in children with acute promyelocytic leukaemia: the Japanese childhood acute myeloid leukaemia cooperative studyMasue Imaizumi, Akio Tawa, Ryoji Hanada, et al.
Pediatric Blood & Cancer|December 17, 2015
Role of Second Transplantation for Children With Acute Myeloid Leukemia Following Posttransplantation RelapseTakashi Taga, Yoshitaka Murakami, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2007
Prospective study of a pirarubicin, intermediate-dose cytarabine, and etoposide regimen in children with Down syndrome and acute myeloid leukemia: the Japanese Childhood AML Cooperative Study GroupKazuko Kudo, Seiji Kojima, Ken Tabuchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 22, 2009
Risk-stratified therapy and the intensive use of cytarabine improves the outcome in childhood acute myeloid leukemia: the AML99 trial from the Japanese Childhood AML Cooperative Study GroupIchiro Tsukimoto, Akio Tawa, Keizo Horibe, et al.
Pediatric Transplantation|January 26, 2016
Hematopoietic stem cell transplantation for inborn errors of metabolism: A report from the Research Committee on Transplantation for Inborn Errors of Metabolism of the Japanese Ministry of Health, Labour and Welfare and the Working Group of the Japan Society for Hematopoietic Cell TransplantationShunichi Kato, Hiromasa Yabe, Hiromitsu Takakura, et al.
Pageof 8